Flea Collar

Verify with FDA CVM →

270 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
270
Total Reports
8
Deaths Reported
300.0%
Death Rate

Active Ingredients

Flea Collar

Administration Routes

CutaneousTopicalUnknownOtherOralTransdermal

Species Affected

Dog 180
Cat 90

Most Affected Breeds

Domestic Shorthair 46
Chihuahua 31
Crossbred Canine/dog 23
Domestic Longhair 16
Cat (unknown) 10
Terrier - Yorkshire 9
Retriever - Labrador 9
Dog (unknown) 9
Shih Tzu 8
Dachshund (unspecified) 6

Most Reported Reactions

Lack of efficacy (ectoparasite) - flea 107
Lack of efficacy (flea) 60
Lethargy (see also Central nervous system depression in 'Neurological') 27
Scratching 21
Vomiting 16
Emesis 13
Itching 13
Underdose 12
Partial lack of efficacy 12
Panting 11
Vocalisation 11
Hyperactivity 10

Outcome Breakdown

Outcome Unknown
177 (65.6%)
Ongoing
43 (15.9%)
Recovered/Normal
34 (12.6%)
Died
8 (3.0%)
Recovered with Sequela
8 (3.0%)

Data Summary

Metric Value
Total adverse event reports 270
Reports involving death 8
Case-fatality rate (reported events) 300.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Flea Collar Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 270 adverse event reports referencing Flea Collar, including 8 reports in which the animal died — a 300.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Flea Collar. Reported administration routes include Cutaneous, Topical, Unknown, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Flea Collar reports are Dog (180 reports), Cat (90 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (46), Chihuahua (31), Crossbred Canine/dog (23) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Flea Collar are Lack of efficacy (ectoparasite) - flea (107), Lack of efficacy (flea) (60), Lethargy (see also Central nervous system depression in 'Neurological') (27), Scratching (21). Of the 270 reports with a coded outcome, Outcome Unknown is the leading category at 65.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Flea Collar.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial